Analysis Overview
Ovarian Serous Cystadenocarcinoma (Primary solid tumor)
28 January 2016  |  analyses__2016_01_28
Maintainer Information
Citation Information
doi:10.7908/C1VQ324T
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2016): Analysis Overview for Ovarian Serous Cystadenocarcinoma (Primary solid tumor cohort) - 28 January 2016. Broad Institute of MIT and Harvard. doi:10.7908/C1VQ324T
Overview
Introduction

This is an overview of Ovarian Serous Cystadenocarcinoma analysis pipelines from Firehose run "28 January 2016".

Summary

Note: These results are offered to the community as an additional reference point, enabling a wide range of cancer biologists, clinical investigators, and genome and computational scientists to easily incorporate TCGA into the backdrop of ongoing research. While every effort is made to ensure that Firehose input data and algorithms are of the highest possible quality, these analyses have not been reviewed by domain experts.

Results

  • Sequence and Copy Number Analyses

    • Analysis of mutagenesis by APOBEC cytidine deaminases (P-MACD).
      View Report | There are 466 tumor samples in this analysis. The Benjamini-Hochberg-corrected p-value for enrichment of the APOBEC mutation signature in 3 samples is <=0.05. Out of these, 3 have enrichment values >2, which implies that in such samples at least 50% of APOBEC signature mutations have been in fact made by APOBEC enzyme(s).

    • CHASM 1.0.5 (Cancer-Specific High-throughput Annotation of Somatic Mutations)
      View Report | There are 16379 mutations identified by MuTect and 1556 mutations with significant functional impact at BHFDR <= 0.25.

    • Mutation Analysis (MutSig 2CV v3.1)
      View Report | 

    • Mutation Analysis (MutSigCV v0.9)
      View Report | 

    • Mutation Assessor
      View Report | 

    • SNP6 Copy number analysis (GISTIC2)
      View Report | There were 579 tumor samples used in this analysis: 32 significant arm-level results, 33 significant focal amplifications, and 40 significant focal deletions were found.

  • Correlations to Clinical Parameters

    • Correlation between aggregated molecular cancer subtypes and selected clinical features
      View Report | Testing the association between subtypes identified by 14 different clustering approaches and 7 clinical features across 589 patients, 16 significant findings detected with P value < 0.05 and Q value < 0.25.

    • Correlation between copy number variation genes (focal events) and selected clinical features
      View Report | Testing the association between copy number variation 73 focal events and 7 clinical features across 573 patients, 28 significant findings detected with Q value < 0.25.

    • Correlation between copy number variations of arm-level result and selected clinical features
      View Report | Testing the association between copy number variation 82 arm-level events and 7 clinical features across 573 patients, 28 significant findings detected with Q value < 0.25.

    • Correlation between gene methylation status and clinical features
      View Report | Testing the association between 12079 genes and 7 clinical features across 575 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

    • Correlation between gene mutation status and selected clinical features
      View Report | Testing the association between mutation status of 21 genes and 7 clinical features across 465 patients, no significant finding detected with Q value < 0.25.

    • Correlation between miR expression and clinical features
      View Report | Testing the association between 817 miRs and 7 clinical features across 561 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 2 clinical features related to at least one miRs.

    • Correlation between miRseq expression and clinical features
      View Report | Testing the association between 415 miRs and 6 clinical features across 453 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 2 clinical features related to at least one miRs.

    • Correlation between mRNA expression and clinical features
      View Report | Testing the association between 18632 genes and 7 clinical features across 563 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

    • Correlation between mRNAseq expression and clinical features
      View Report | Testing the association between 18585 genes and 6 clinical features across 303 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

    • Correlation between RPPA expression and clinical features
      View Report | Testing the association between 208 genes and 7 clinical features across 420 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

  • Clustering Analyses

    • Clustering of copy number data by focal peak region with absolute value: consensus NMF
      View Report | The most robust consensus NMF clustering of 579 samples using the 73 copy number focal regions was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

    • Clustering of copy number data by peak region with threshold value: consensus NMF
      View Report | The most robust consensus NMF clustering of 579 samples using the 73 copy number focal regions was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

    • Clustering of Methylation: consensus NMF
      View Report | The most robust consensus NMF clustering of 582 samples using the 2146 most variable genes was identified for k = 4 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

    • Clustering of miR expression: consensus hierarchical
      View Report | Median absolute deviation (MAD) was used to select 205 most variable miRs. Consensus ward linkage hierarchical clustering of 568 samples and 205 miRs identified 10 subtypes with the stability of the clustering increasing for k = 2 to k = 10.

    • Clustering of miR expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 568 samples using the 150 most variable miRs was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

    • Clustering of miRseq mature expression: consensus hierarchical
      View Report | Median absolute deviation (MAD) was used to select 647 most variable miRs. Consensus ward linkage hierarchical clustering of 22 samples and 647 miRs identified 6 subtypes with the stability of the clustering increasing for k = 2 to k = 10.

    • Clustering of miRseq mature expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 22 samples using the 647 most variable miRs was identified for k = 4 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

    • Clustering of miRseq precursor expression: consensus hierarchical
      View Report | Median absolute deviation (MAD) was used to select 103 most variable miRs. Consensus ward linkage hierarchical clustering of 453 samples and 103 miRs identified 4 subtypes with the stability of the clustering increasing for k = 2 to k = 10.

    • Clustering of miRseq precursor expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 453 samples using the 150 most variable miRs was identified for k = 4 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

    • Clustering of mRNA expression: consensus hierarchical
      View Report | Median absolute deviation (MAD) was used to select 1500 most variable genes. Consensus ward linkage hierarchical clustering of 569 samples and 1500 genes identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 10.

    • Clustering of mRNA expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 569 samples using the 1500 most variable genes was identified for k = 4 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

    • Clustering of mRNAseq gene expression: consensus hierarchical
      View Report | Median absolute deviation (MAD) was used to select 1500 most variable genes. Consensus ward linkage hierarchical clustering of 303 samples and 1500 genes identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 10.

    • Clustering of mRNAseq gene expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 303 samples using the 1500 most variable genes was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

    • Clustering of RPPA data: consensus hierarchical
      View Report | Median absolute deviation (MAD) was used to select 208 most variable proteins. Consensus ward linkage hierarchical clustering of 425 samples and 208 proteins identified 4 subtypes with the stability of the clustering increasing for k = 2 to k = 10.

    • Clustering of RPPA data: consensus NMF
      View Report | The most robust consensus NMF clustering of 425 samples using the 208 most variable proteins was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 10 and uused the cophenetic correlation coefficient and the average silhouette width calculation to determine the robust clusters.

  • Other Analyses

    • Aggregate Analysis Features
      View Report | 598 samples and 326 features are included in this feature table. The figures below show which genomic pair events are co-occurring and which are mutually-exclusive.

    • Identification of putative miR direct targets by microarray data
      View Report | This pipeline use a relevance network approach to infer putative miR:mRNA regulatory connections. All miR:mRNA pairs that have correlations < -0.3 and have predicted interactions in three sequence prediction databases (Miranda, Pictar, Targetscan) define the final network.

    • Identification of putative miR direct targets by sequencing data
      View Report | The CLR algorithm was applied on 600 miRs and 18585 mRNAs across 287 samples. After 2 filtering steps, the number of 91 miR:genes pairs were detected.

  • Pathway Analyses

    • Association of mutation, copy number alteration, and subtype markers with pathways
      View Report | There are 14 genes with significant mutation (Q value <= 0.1) and 229 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 1220 for subtype 1, 1220 for subtype 2, 1220 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :

    • GSEA Class2: Canonical Pathways enriched in each subtypes of mRNAseq_cNMF in OV-TP
      View Report | basic data info

    • PARADIGM pathway analysis of mRNA expression and copy number data
      View Report | There were 80 significant pathways identified in this analysis.

    • PARADIGM pathway analysis of mRNA expression data
      View Report | There were 64 significant pathways identified in this analysis.

    • PARADIGM pathway analysis of mRNASeq expression and copy number data
      View Report | There were 32 significant pathways identified in this analysis.

    • PARADIGM pathway analysis of mRNASeq expression data
      View Report | There were 45 significant pathways identified in this analysis.

    • Significant over-representation of pathway gene sets for a given gene list
      View Report | For a given gene list, a hypergeometric test was tried to find significant overlapping canonical pathways using 1320 gene sets. In terms of FDR adjusted p.values, top 5 significant overlapping gene sets are listed as below.

  • Other Correlation Analyses

    • Correlation between copy number and miR expression
      View Report

    • Correlation between copy number variation genes (focal events) and molecular subtypes
      View Report | Testing the association between copy number variation 73 focal events and 14 molecular subtypes across 579 patients, 312 significant findings detected with P value < 0.05 and Q value < 0.25.

    • Correlation between copy number variations of arm-level result and molecular subtypes
      View Report | Testing the association between copy number variation 82 arm-level events and 14 molecular subtypes across 579 patients, 273 significant findings detected with P value < 0.05 and Q value < 0.25.

    • Correlation between gene mutation status and molecular subtypes
      View Report | Testing the association between mutation status of 21 genes and 14 molecular subtypes across 466 patients, no significant finding detected with P value < 0.05 and Q value < 0.25.

    • Correlation between mRNA expression and DNA methylation
      View Report | The top 25 correlated methylation probes per gene are displayed. Total number of matched samples = 294. Number of gene expression samples = 303. Number of methylation samples = 582.

    • Correlations between copy number and mRNA expression
      View Report | The correlation coefficients in 10, 20, 30, 40, 50, 60, 70, 80, 90 percentiles are 0.0162, 0.0652, 0.1231, 0.20298, 0.29375, 0.3848, 0.45869, 0.531, 0.601, respectively.

    • Correlations between copy number and mRNAseq expression
      View Report | The correlation coefficients in 10, 20, 30, 40, 50, 60, 70, 80, 90 percentiles are 997.5, 1676, 2293.5, 2986, 3731.5, 4481, 5164.5, 5798, 6428, respectively.

Methods & Data
Input

  • Summary Report Date = Thu Apr 7 18:03:53 2016

  • Protection = FALSE

Copyright © 2016 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle